Sociedad Americana de Hirudoterapia

Buccalin-Like Peptide

Putative neuroactive signaling peptide identified in leech salivary tissue — named by analogy to mollusc buccalin; function speculative.

Preclínico / mecanísticoLast updated: 2026-05-26 · Reviewed by ASH Editorial Board
Molecular weight of Buccalin-Like Peptide compared with other characterized leech-derived compoundsHementerin80 kDaHementin80 kDaHementin-Like Protein (HLP-1)80 kDaLeech Collagenase70 kDaHaemadipsa yanyuanensis Progr…70 kDaLeech Apyrase67 kDaCalin65 kDaHyaluronidase60 kDaAntithrombin III binding prot…58 kDaCollagenolytic Fibrinolysin55 kDaLeech Thrombospondin-Like Pro…50 kDaBuccalin-Like Peptide1 kDa
Molecular weight (kilodaltons) of Buccalin-Like Peptide (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic
Page type
Compound profile
Evidence type
Putative neuroactive signaling peptide identified in leech salivary tissue — named by analogy to mollusc buccalin; function speculative.
Evidence level
Mechanistic discussion
Drug vs leech
Purified natural compound

Clinical translation limit

This peptide is named by sequence analogy only; biological function in leech is not established. No FDA-approved derivative exists and no clinical efficacy is claimed.

Molecular Profile

Category
Other
Evidence tier
Preclinical
Molecular weight
1,000 Da
Source species
Hirudo medicinalis
Discovered
2018
Buccalin-Like Peptide molecular structure

Biological Targets

  • neuropeptide signaling (mechanism under characterization)

External Resources

    Related Other Compounds

    Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.